CHARLES SCHWAB INVESTMENT MANAGEMENT INC - SPECTRUM PHARMACEUTICALS INC ownership

SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 165 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.26 and the average weighting 0.0%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of SPECTRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$79,380
+28.0%
82,6870.0%0.00%
Q1 2023$62,015
+103.5%
82,6870.0%0.00%
Q4 2022$30,470
-15.4%
82,6870.0%0.00%
Q3 2022$36,000
-93.6%
82,687
-80.9%
0.00%
Q1 2022$559,000
+7.3%
432,628
+5.5%
0.00%
Q4 2021$521,000
-41.7%
409,902
+0.0%
0.00%
Q3 2021$893,000
-78.3%
409,725
-62.6%
0.00%
-100.0%
Q2 2021$4,109,000
+27.5%
1,095,589
+10.8%
0.00%0.0%
Q1 2021$3,223,000
-2.6%
988,371
+1.9%
0.00%0.0%
Q4 2020$3,309,000
-16.0%
970,122
+0.5%
0.00%
-50.0%
Q3 2020$3,938,000
+53.9%
964,983
+27.5%
0.00%
+100.0%
Q2 2020$2,558,000
+57.7%
756,618
+8.7%
0.00%0.0%
Q1 2020$1,622,000
-35.4%
695,997
+0.9%
0.00%0.0%
Q4 2019$2,511,000
-55.2%
689,634
+2.1%
0.00%
-66.7%
Q3 2019$5,601,000
+2.2%
675,176
+6.1%
0.00%0.0%
Q2 2019$5,478,000
-14.5%
636,173
+6.2%
0.00%
-25.0%
Q1 2019$6,404,000
+31.4%
599,000
+7.5%
0.00%0.0%
Q4 2018$4,874,000
-51.6%
557,014
-7.1%
0.00%
-42.9%
Q3 2018$10,073,000
-15.0%
599,558
+6.0%
0.01%
-22.2%
Q2 2018$11,853,000
+54.0%
565,479
+18.2%
0.01%
+50.0%
Q1 2018$7,698,000
-11.4%
478,404
+4.4%
0.01%
-14.3%
Q4 2017$8,688,000
+22.0%
458,450
-9.4%
0.01%
+16.7%
Q3 2017$7,119,000
+119.5%
505,909
+16.2%
0.01%
+100.0%
Q2 2017$3,244,000
-8.6%
435,422
-20.3%
0.00%
-25.0%
Q1 2017$3,550,000
-27.3%
546,010
-50.4%
0.00%
-20.0%
Q4 2016$4,880,000
-11.6%
1,101,408
-6.8%
0.01%
-16.7%
Q3 2016$5,521,000
-13.6%
1,182,098
+21.5%
0.01%
-25.0%
Q2 2016$6,392,000
+11.0%
972,888
+7.5%
0.01%0.0%
Q1 2016$5,756,000
+3.2%
904,994
-2.2%
0.01%0.0%
Q4 2015$5,578,000
+0.3%
925,032
-0.5%
0.01%0.0%
Q3 2015$5,561,000
-8.4%
929,779
+4.7%
0.01%0.0%
Q2 2015$6,074,000
+13.3%
887,894
+0.5%
0.01%0.0%
Q1 2015$5,362,000
-2.8%
883,302
+11.0%
0.01%0.0%
Q4 2014$5,517,000
+27.0%
796,006
+49.2%
0.01%
+14.3%
Q3 2014$4,343,000
+113.5%
533,432
+113.2%
0.01%
+133.3%
Q2 2014$2,034,000
+66.2%
250,144
+60.3%
0.00%
+50.0%
Q1 2014$1,224,000
-9.5%
156,058
+2.1%
0.00%
-33.3%
Q4 2013$1,353,000
+8.1%
152,818
+2.6%
0.00%0.0%
Q3 2013$1,252,000
+20.5%
148,930
+12.4%
0.00%
+50.0%
Q2 2013$1,039,000132,4600.00%
Other shareholders
SPECTRUM PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Consonance Capital Management LP 2,020,583$15,053,0001.77%
Piermont Capital Management Inc. 247,882$1,847,0000.53%
BARD ASSOCIATES INC 129,380$964,0000.44%
Sonora Investment Management, LLC 239,202$1,782,055,0000.34%
TFS CAPITAL LLC 97,526$727,0000.28%
Alambic Investment Management, L.P. 165,001$1,229,0000.15%
KENNEDY CAPITAL MANAGEMENT LLC 491,075$3,659,0000.07%
Renaissance Technologies 6,071,817$45,235,0000.06%
Granite Investment Partners, LLC 97,023$723,0000.05%
ClariVest Asset Management LLC 241,909$1,802,0000.04%
View complete list of SPECTRUM PHARMACEUTICALS INC shareholders